Marie Bex

2.7k total citations
39 papers, 1.8k citations indexed

About

Marie Bex is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Marie Bex has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Marie Bex's work include Pituitary Gland Disorders and Treatments (25 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Adrenal Hormones and Disorders (8 papers). Marie Bex is often cited by papers focused on Pituitary Gland Disorders and Treatments (25 papers), Growth Hormone and Insulin-like Growth Factors (18 papers) and Adrenal Hormones and Disorders (8 papers). Marie Bex collaborates with scholars based in Belgium, United States and Netherlands. Marie Bex's co-authors include Roger Bouillon, Dominique Maiter, Roger Abs, Guy T’Sjoen, Brigitte Velkeniers, Dirk Vanderschueren, E. Van Herck, Steven Boonen, Orsalia Alexopoulou and P. De Nayer and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Marie Bex

39 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marie Bex Belgium	21	1.2k	423	364	338	219	39	1.8k
Stefania Bonadonna Italy	21	1.2k 1.0×	338 0.8×	280 0.8×	131 0.4×	182 0.8×	40	1.6k
Zoe Efstathiadou Greece	22	692 0.6×	338 0.8×	308 0.8×	110 0.3×	242 1.1×	61	1.4k
Marcello Filopanti Italy	20	458 0.4×	223 0.5×	509 1.4×	240 0.7×	112 0.5×	41	1.3k
Giorgio Borretta Italy	24	1.7k 1.4×	1.4k 3.3×	308 0.8×	265 0.8×	103 0.5×	87	2.7k
Seong Yeon Kim South Korea	22	494 0.4×	423 1.0×	487 1.3×	128 0.4×	371 1.7×	63	1.5k
Anya Rothenbühler France	23	371 0.3×	311 0.7×	348 1.0×	422 1.2×	122 0.6×	83	1.6k
P E Belchetz United Kingdom	23	1.7k 1.4×	362 0.9×	279 0.8×	327 1.0×	55 0.3×	55	2.4k
Rue‐Tsuan Liu Taiwan	25	1.0k 0.9×	269 0.6×	570 1.6×	211 0.6×	65 0.3×	57	1.9k
Antonella Giampietro Italy	26	1.5k 1.3×	491 1.2×	233 0.6×	111 0.3×	75 0.3×	107	1.8k
Anna G Nilsson Sweden	18	788 0.7×	267 0.6×	252 0.7×	92 0.3×	347 1.6×	30	1.3k

Countries citing papers authored by Marie Bex

Since Specialization

Citations

This map shows the geographic impact of Marie Bex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Bex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Bex more than expected).

Fields of papers citing papers by Marie Bex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Bex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Bex. The network helps show where Marie Bex may publish in the future.

Co-authorship network of co-authors of Marie Bex

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Bex. A scholar is included among the top collaborators of Marie Bex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Bex. Marie Bex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleseriu, Maria, Rosario Pivonello, John Newell‐Price, et al.. (2025). Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies. Pituitary. 28(1). 22–22. 9 indexed citations

Feelders, Richard A., Maria Fleseriu, Pınar Kadıoğlu, et al.. (2023). Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease. Frontiers in Endocrinology. 14. 1165681–1165681. 11 indexed citations

Gadelha, Mônica R., Peter J. Snyder, Przemysław Witek, et al.. (2023). Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension. Frontiers in Endocrinology. 14. 1236465–1236465. 25 indexed citations

Gadelha, Mônica R., Marie Bex, Richard A. Feelders, et al.. (2022). Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. The Journal of Clinical Endocrinology & Metabolism. 107(7). e2882–e2895. 66 indexed citations

Roose, Heleen, Hiroto Kobayashi, Raf Sciot, et al.. (2022). Exploring stem cell biology in pituitary tumors and derived organoids. Endocrine Related Cancer. 29(7). 427–450. 14 indexed citations

Burlacu, Maria‐Cristina, Roberto Attanasio, László Hegedüs, et al.. (2022). Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey. Thyroid Research. 15(1). 3–3. 13 indexed citations

Pauwels, Elin, Sofie Celen, Mathilde Vandamme, et al.. (2020). Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 313–315. 19 indexed citations

Geer, Eliza B., Roberto Salvatori, Атанаска Еленкова, et al.. (2020). Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome. Pituitary. 24(1). 104–115. 20 indexed citations

Gadelha, Mônica R., Marie Bex, Annamaria Colao, et al.. (2020). Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs. Frontiers in Endocrinology. 10. 931–931. 31 indexed citations

10.

Maiter, Dominique, Marie Bex, Laurent Vroonen, et al.. (2016). Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients. Annales d Endocrinologie. 77(5). 578–585. 19 indexed citations

11.

Verhelst, Johan, Brigitte Velkeniers, Dominique Maiter, et al.. (2012). Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly. European Journal of Endocrinology. 168(2). 177–184. 20 indexed citations

12.

Hannan, Fadil, M. Andrew Nesbit, Paul T. Christie, et al.. (2010). A homozygous inactivating calcium‐sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Clinical Endocrinology. 73(6). 715–722. 37 indexed citations

13.

Freson, Kathleen, Benedetta Izzi, Veerle Labarque, et al.. (2008). GNAS Defects Identified by Stimulatory G Protein α-Subunit Signalling Studies in Platelets. The Journal of Clinical Endocrinology & Metabolism. 93(12). 4851–4859. 30 indexed citations

14.

Alexopoulou, Orsalia, Marie Bex, Roger Abs, et al.. (2008). Divergence between Growth Hormone and Insulin-Like Growth Factor-I Concentrations in the Follow-Up of Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 93(4). 1324–1330. 97 indexed citations

15.

Hannan, Fadil, Paul T. Christie, Willy Lissens, et al.. (2007). A novel homozygous inactivating mutation, Pro339Thr, of the calcium-sensing receptor is associated with isolated primary hyperparathyroidism. 1 indexed citations

16.

Bex, Marie, Roger Abs, Guy T’Sjoen, et al.. (2007). AcroBel – the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. European Journal of Endocrinology. 157(4). 399–409. 153 indexed citations

17.

Caron, P., Marie Bex, D. R. Cullen, et al.. (2004). One‐year follow‐up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel^®. Clinical Endocrinology. 60(6). 734–740. 66 indexed citations

18.

Bouillon, Roger, Marie Bex, Dirk Vanderschueren, & Steven Boonen. (2004). Estrogens Are Essential for Male Pubertal Periosteal Bone Expansion. The Journal of Clinical Endocrinology & Metabolism. 89(12). 6025–6029. 144 indexed citations

19.

Glinoer, Daniel, P. De Nayer, & Marie Bex. (2001). Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. European Journal of Endocrinology. 144(5). 475–483. 89 indexed citations

20.

Bouillon, Roger, L. Verresen, Frederik Staels, et al.. (1993). The Measurement of Fecal Thyroxine in the Diagnosis of Thyrotoxicosis Factitia. Thyroid. 3(2). 101–103. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact